TY - JOUR AU - Barrington, S. F. AU - Mikhaeel, N. G. AU - Kostakoglu, L. PY - 2014 DA - 2014// TI - Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group JO - J Clin Oncol. VL - 32 UR - https://doi.org/10.1200/JCO.2013.53.5229 DO - 10.1200/JCO.2013.53.5229 ID - Barrington2014 ER - TY - JOUR AU - Gallamini, A. AU - Barrington, S. F. AU - Biggi, A. PY - 2014 DA - 2014// TI - The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale JO - Haematologica VL - 99 UR - https://doi.org/10.3324/haematol.2013.103218 DO - 10.3324/haematol.2013.103218 ID - Gallamini2014 ER - TY - JOUR AU - Wahl, R. L. AU - Zasadny, K. AU - Helvie, M. AU - Hutchins, G. D. AU - Weber, B. AU - Cody, R. PY - 1993 DA - 1993// TI - Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation JO - J Clin Oncol VL - 11 UR - https://doi.org/10.1200/JCO.1993.11.11.2101 DO - 10.1200/JCO.1993.11.11.2101 ID - Wahl1993 ER - TY - JOUR AU - Connolly, R. M. AU - Leal, J. P. AU - Solnes, L. PY - 2019 DA - 2019// TI - TBCRC026: phase II trial correlating standardized uptake value with pathologic complete response to pertuzumab and trastuzumab in breast cancer JO - J Clin Oncol VL - 37 UR - https://doi.org/10.1200/JCO.2018.78.7986 DO - 10.1200/JCO.2018.78.7986 ID - Connolly2019 ER - TY - JOUR AU - Wahl, R. L. AU - Jacene, H. AU - Kasamon, Y. AU - Lodge, M. A. PY - 2009 DA - 2009// TI - From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors JO - J Nucl Med VL - 50 UR - https://doi.org/10.2967/jnumed.108.057307 DO - 10.2967/jnumed.108.057307 ID - Wahl2009 ER - TY - JOUR AU - Jh, O. AU - Lodge, M. A. AU - Wahl, R. L. PY - 2016 DA - 2016// TI - Practical PERCIST: a simplified guide to PET response criteria in solid tumors 1.0 JO - Radiology VL - 280 UR - https://doi.org/10.1148/radiol.2016142043 DO - 10.1148/radiol.2016142043 ID - Jh2016 ER - TY - JOUR AU - Lodge, M. A. AU - Chaudhry, M. A. AU - Wahl, R. L. PY - 2012 DA - 2012// TI - Noise considerations for PET quantification using maximum and peak standardized uptake value JO - J Nucl Med VL - 53 UR - https://doi.org/10.2967/jnumed.111.101733 DO - 10.2967/jnumed.111.101733 ID - Lodge2012 ER - TY - JOUR AU - Quak, E. AU - Roux, P. Y. AU - Lasnon, C. PY - 2016 DA - 2016// TI - Does PET SUV harmonization affect PERCIST response classification? JO - J Nucl Med VL - 57 UR - https://doi.org/10.2967/jnumed.115.171983 DO - 10.2967/jnumed.115.171983 ID - Quak2016 ER - TY - JOUR AU - Jh, O. AU - Jacene, H. AU - Luber, B. PY - 2017 DA - 2017// TI - Quantitation of cancer treatment response by (18)F-FDG PET/CT: multicenter assessment of measurement variability JO - J Nucl Med. VL - 58 UR - https://doi.org/10.2967/jnumed.117.189605 DO - 10.2967/jnumed.117.189605 ID - Jh2017 ER - TY - JOUR AU - Krippendorff, K. PY - 2004 DA - 2004// TI - Measuring the reliability of qualitative text analysis data JO - Qual Quant VL - 38 UR - https://doi.org/10.1007/s11135-004-8107-7 DO - 10.1007/s11135-004-8107-7 ID - Krippendorff2004 ER - TY - JOUR AU - Ding, Q. AU - Cheng, X. AU - Yang, L. PY - 2014 DA - 2014// TI - PET/CT evaluation of response to chemotherapy in non-small cell lung cancer: PET response criteria in solid tumors (PERCIST) versus response evaluation criteria in solid tumors (RECIST) JO - J Thorac Dis VL - 6 ID - Ding2014 ER - TY - JOUR AU - Lodge, M. A. PY - 2017 DA - 2017// TI - Repeatability of SUV in oncologic (18)F-FDG PET JO - J Nucl Med VL - 58 UR - https://doi.org/10.2967/jnumed.116.186353 DO - 10.2967/jnumed.116.186353 ID - Lodge2017 ER - TY - JOUR AU - Mhlanga, J. C. AU - Chirindel, A. AU - Lodge, M. A. AU - Wahl, R. L. AU - Subramaniam, R. M. PY - 2018 DA - 2018// TI - Quantitative PET/CT in clinical practice: assessing the agreement of PET tumor indices using different clinical reading platforms JO - Nucl Med Commun VL - 39 UR - https://doi.org/10.1097/MNM.0000000000000786 DO - 10.1097/MNM.0000000000000786 ID - Mhlanga2018 ER - TY - JOUR AU - Fox, J. J. AU - Autran-Blanc, E. AU - Morris, M. J. PY - 2011 DA - 2011// TI - Practical approach for comparative analysis of multilesion molecular imaging using a semiautomated program for PET/CT JO - J Nucl Med VL - 52 UR - https://doi.org/10.2967/jnumed.111.089326 DO - 10.2967/jnumed.111.089326 ID - Fox2011 ER - TY - JOUR AU - Fraum, T. J. AU - Fowler, K. J. AU - Crandall, J. P. PY - 2019 DA - 2019// TI - Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis JO - J Nucl Med VL - 60 UR - https://doi.org/10.2967/jnumed.118.218735 DO - 10.2967/jnumed.118.218735 ID - Fraum2019 ER - TY - JOUR AU - Kumar, V. AU - Nath, K. AU - Berman, C. G. PY - 2013 DA - 2013// TI - Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings JO - Clin Nucl Med VL - 38 UR - https://doi.org/10.1097/RLU.0b013e318279ffdf DO - 10.1097/RLU.0b013e318279ffdf ID - Kumar2013 ER - TY - JOUR AU - Burggraaff, C. N. AU - Cornelisse, A. C. AU - Hoekstra, O. S. PY - 2018 DA - 2018// TI - Interobserver agreement of interim and end-of-treatment (18)F-FDG PET/CT in diffuse large b-cell lymphoma: impact on clinical practice and trials JO - J Nucl Med VL - 59 UR - https://doi.org/10.2967/jnumed.118.210807 DO - 10.2967/jnumed.118.210807 ID - Burggraaff2018 ER - TY - JOUR AU - Han, E. J. AU - O, J. H. AU - Yoon, H. PY - 2016 DA - 2016// TI - FDG PET/CT response in diffuse large B-cell lymphoma: reader variability and association with clinical outcome JO - Medicine (Baltimore) VL - 95 UR - https://doi.org/10.1097/MD.0000000000004983 DO - 10.1097/MD.0000000000004983 ID - Han2016 ER - TY - JOUR AU - Pinker, K. AU - Riedl, C. AU - Weber, W. A. PY - 2017 DA - 2017// TI - Evaluating tumor response with FDG PET: updates on PERCIST, comparison with EORTC criteria and clues to future developments JO - Eur J Nucl Med Mol Imaging VL - 44 UR - https://doi.org/10.1007/s00259-017-3687-3 DO - 10.1007/s00259-017-3687-3 ID - Pinker2017 ER - TY - JOUR AU - Tixier, F. AU - Hatt, M. AU - Valla, C. PY - 2014 DA - 2014// TI - Visual versus quantitative assessment of intratumor 18F-FDG PET uptake heterogeneity: prognostic value in non-small cell lung cancer JO - J Nucl Med VL - 55 UR - https://doi.org/10.2967/jnumed.113.133389 DO - 10.2967/jnumed.113.133389 ID - Tixier2014 ER - TY - JOUR AU - Huang, W. AU - Fan, M. AU - Liu, B. PY - 2014 DA - 2014// TI - Value of metabolic tumor volume on repeated 18F-FDG PET/CT for early prediction of survival in locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy JO - J Nucl Med VL - 55 UR - https://doi.org/10.2967/jnumed.114.142919 DO - 10.2967/jnumed.114.142919 ID - Huang2014 ER - TY - JOUR AU - Lee, J. W. AU - Lee, S. M. PY - 2018 DA - 2018// TI - Radiomics in oncological PET/CT: clinical applications JO - Nucl Med Mol Imaging VL - 52 UR - https://doi.org/10.1007/s13139-017-0500-y DO - 10.1007/s13139-017-0500-y ID - Lee2018 ER -